News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Vogt Frederick G
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/17/2023 |
4
| Vogt Frederick G (Interim CEO & General Counsel) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 8,851 shares
@ $7.76, valued at
$68.7k
Exercised 20,834 restricted stock units
@ $0 |
|
04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/06/2023 |
4
| Vogt Frederick G (See Remarks) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns:
| Granted 125,000 restricted stock units
@ $0 Granted 500,000 options to buy
@ $7.12, valued at
$3.6M
|
|
01/19/2023 |
4
| Vogt Frederick G (Interim CEO & General Counsel) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 36,441 shares
@ $6.43, valued at
$234.3k
Exercised 83,325 restricted stock units
@ $0 |
|
11/28/2022 |
4
| Vogt Frederick G (Interim CEO & General Counsel) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns:
| Bought 1,000 shares
@ $5.98, valued at
$6k
|
|
06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/19/2022 |
4
| Vogt Frederick G (Interim CEO & General Counsel) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns:
| Granted 250,000 restricted stock units
@ $0 |
|
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/06/2019 |
4
| Vogt Frederick G (General Counsel) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns:
| Granted 200,000 options to buy
@ $11.26, valued at
$2.3M
|
|
01/08/2018 |
4
| Vogt Frederick G (General Counsel) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns:
| Granted 37,400 options to buy
@ $8, valued at
$299.2k
|
|
10/20/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|